Chitose Bio Evolution
Chitose Bio Evolution raises $49M through third-party allotment for expansion
Chitose Bio Evolution, a Singapore-based biotech firm and the headquarters of Chitose Group, has announced the issuance of new shares of JPY 7.3 billion ($49 million) through a third-party allotment for expansion.
Singapore’s CHITOSE Group raises $6.2M from Japan’s SMBC
Singapore-based biotech firm Chitose Bio Evolution Pte. Ltd. has announced the issuance of new shares of JPY 1 billion ($6.2 million) through a third-party allotment to Sumitomo Mitsui Banking Corporation (SMBC).
